AtriCure
ATRC
ATRC
217 hedge funds and large institutions have $2.78B invested in AtriCure in 2022 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 77 increasing their positions, 85 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
9% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 85
8% less capital invested
Capital invested by funds: $3.03B → $2.78B (-$248M)
Holders
217
Holding in Top 10
3
Calls
$269K
Puts
–
Top Buyers
| 1 | +$27.7M | |
| 2 | +$23.3M | |
| 3 | +$23.1M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$12.8M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$6.48M |
Top Sellers
| 1 | -$31.2M | |
| 2 | -$15.5M | |
| 3 | -$12.2M | |
| 4 |
Bank of New York Mellon
New York
|
-$10.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$9.88M |